FOXO Technologies: Funding, Investors & Team (Sep 2026)
FOXO Technologies is revolutionizing the longevity insurance industry worldwide by utilizing cutting-edge underwriting methods and consumer engagement tools that are founded on epigenetic technology and knowledge. The company employs AI-driven bioinformatics and microarray technologies to create and market epigenetic biomarkers for health and aging, offering laboratory services, microarray design, and bioinformatics software solutions to insurers, health researchers, and life science companies to access unique information on lifespan.
FOXO Technologies has raised $4.5M across 3 funding rounds on record, the most recent an undisclosed round of $1.5M announced in Jun 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
FOXO Technologies Company Profile and Key Stats
Latest funding round on record: Jun 2025.
FOXO Technologies Funding Rounds
FOXO Technologies raised $2.8M in an undisclosed round announced in Jun 2024.
6 months later, an undisclosed round of $220k was announced in Dec 2024.
6 months later, an undisclosed round of $1.5M was announced in Jun 2025.
FOXO Technologies Founders and Leadership Team
Contact details for the FOXO Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →FOXO Technologies Funding Compared to Other Biotechnology Startups
FOXO Technologies' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FOXO Technologies in Biotechnology and Minneapolis
Companies Similar to FOXO Technologies
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
FOXO Technologies Funding FAQs
What does FOXO Technologies do?
FOXO Technologies is revolutionizing the longevity insurance industry worldwide by utilizing cutting-edge underwriting methods and consumer engagement tools that are founded on epigenetic technology and knowledge. The company employs AI-driven bioinformatics and microarray technologies to create and market epigenetic biomarkers for health and aging, offering laboratory services, microarray design, and bioinformatics software solutions to insurers, health researchers, and life science companies to access unique information on lifespan.
How much funding has FOXO Technologies raised?
FOXO Technologies has raised $4.5M across 3 rounds on record. The most recent is an undisclosed round of $1.5M announced in Jun 2025.
When did FOXO Technologies last raise funding?
FOXO Technologies' most recent funding round on record is an undisclosed round of $1.5M, announced in Jun 2025.
Who founded FOXO Technologies?
FundedIQ lists Jon R Sabes (Founder) at FOXO Technologies.
Where is FOXO Technologies headquartered?
FOXO Technologies is based in Minneapolis, Minnesota, United States.
How many employees does FOXO Technologies have?
FOXO Technologies is in the 1-10 employee band.
How does FOXO Technologies' funding compare to other Biotechnology startups?
FOXO Technologies' latest round of $1.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's FOXO Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FOXO Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.